Ben Ebede

Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy

Perry Elliott, Brian Drachman, Stephen S. Gottlieb et al. · Circulation Heart Failure · 2021 · 193 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +13

Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years

Fábio Barroso, Daniel P. Judge, Ben Ebede et al. · Amyloid · 2017 · 109 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy

Peter M. Huber, Alison Flynn, Marla B. Sultan et al. · Amyloid · 2019 · 29 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years

Giampaolo Merlini, Teresa Coelho, Márcia Waddington‐Cruz et al. · Neurology and Therapy · 2020 · 29 citations · Full text

Medicine, Neurology, Pharmacotherapy +9

International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction

Sergi Yun, Giovanni Palladini, Eve Cariou et al. · Amyloid · 2024 · 12 citations · Full text

Medicine, Cardiology, Nuclear Medicine +16